• No results found

Allogeneic haematopoietic stem cell donation and transplantation across the MHC class I barrier: "Faster is better than more. More is better than less".

N/A
N/A
Protected

Academic year: 2021

Share "Allogeneic haematopoietic stem cell donation and transplantation across the MHC class I barrier: "Faster is better than more. More is better than less"."

Copied!
13
0
0

Bezig met laden.... (Bekijk nu de volledige tekst)

Hele tekst

(1)

Allogeneic haematopoietic stem cell donation and transplantation

across the MHC class I barrier: "Faster is better than more. More is

better than less".

Heemskerk, M.B.A.

Citation

Heemskerk, M. B. A. (2006, September 28). Allogeneic haematopoietic stem cell donation and transplantation across the MHC class I barrier: "Faster is better than more. More is better than less". Retrieved from https://hdl.handle.net/1887/4578

Version: Corrected Publisher’s Version

License: Licence agreement concerning inclusion of doctoral thesis in theInstitutional Repository of the University of Leiden Downloaded from: https://hdl.handle.net/1887/4578

(2)

4

The HLAMatchmaker algorithm is not a suitable

tool to predict the alloreactive cytotoxic T

lymphocyte response in vitro

(3)
(4)

Abstract

%RWKGRQRUVSHFL¿FDQWL+/$DQWLERGLHVDQGF\WRWR[LF7O\PSKRF\WHVDUHLPSRUWDQWPHGLDWRUV RI JUDIW UHMHFWLRQ $ UHFHQWO\ GHYHORSHG FRPSXWHU DOJRULWKP FDOOHG +/$0DWFKPDNHU GHWHUPLQHVWKHDPLQRDFLGWULSOHWVRQDQWLERG\DFFHVVLEOHVLWHVRIWKH+/$PROHFXOHZKLFKDUH QRWVKDUHGEHWZHHQSDWLHQWDQGGRQRU$SUHYLRXVVWXG\VKRZHGDVWURQJSRVLWLYHFRUUHODWLRQ EHWZHHQ WKH QXPEHU RI WULSOHW PLVPDWFKHV DQG WKH SHUFHQWDJH RI LQGLYLGXDOV SURGXFLQJ +/$DQWLERGLHV,QWKHSUHVHQWVWXG\ZHWHVWHGZKHWKHUWKHQXPEHURIWULSOHWPLVPDWFKHVLV SUHGLFWLYHIRUWKH&7/SIUHTXHQF\in vitro7KHDQDO\VLVZDVSHUIRUPHGRQ+/$'5% DQG'4%LGHQWLFDOSDWLHQWGRQRUFRPELQDWLRQVUHJLVWHUHGE\WKH(XURSGRQRUIRXQGDWLRQ ZLWK D VLQJOH +/$ FODVV , PLVPDWFK DQG LQ KHDOWK\ UHVSRQGHUVWLPXODWRU FRPELQDWLRQV PLVPDWFKHGIRUDWOHDVWRQH+/$FODVV,DQWLJHQ

7KH UHVXOWV VKRZ WKDW WKHUH LV QR VWURQJ FRUUHODWLRQ EHWZHHQ WKH QXPEHU RI WULSOHW PLVPDWFKHV DQG WKH &7/S IUHTXHQF\ (YHQ LQ FDVH RI ]HUR WULSOHW PLVPDWFKHV D KLJK &7/S IUHTXHQF\ FDQ EH IRXQG 7KLV ODFN RI FRUUHODWLRQ LV SUREDEO\ GXH WR WKH IDFW WKDW +/$0DWFKPDNHU FRQVLGHUV RQO\ WULSOHWV RQ DQWLERG\ DFFHVVLEOH SRVLWLRQV ZKLOH &7/V DOVR UHFRJQLVH RWKHU HSLWRSHV RQ WKH +/$ PROHFXOH LQFOXGLQJ WKH ERXQG SHSWLGHV

Introduction

7KH SUHVHQFH RI GRQRU VSHFL¿F DQWL KXPDQ OHXNRF\WH DQWLJHQ +/$  DQWLERGLHV LQ WKH FLUFXODWLRQRIDWUDQVSODQWUHFLSLHQWKDVDQHJDWLYHLPSDFWRQWUDQVSODQWDWLRQRXWFRPH17KLV

GRQRUVSHFL¿FKXPRUDODOORLPPXQLW\PD\H[LVWLQLQGLYLGXDOVZKRKDYHEHHQLPPXQLVHGDV DUHVXOWRIEORRGWUDQVIXVLRQVSUHJQDQFLHVRUIDLOHGWUDQVSODQWV+\SHUDFXWHJUDIWUHMHFWLRQ

ZKLFK LV WKH GLUHFW FRQVHTXHQFH RI SUHH[LVWLQJ GRQRU UHDFWLYH DQWL +/$ DQWLERGLHV KDV EHFRPH UDUH DIWHU WKH LQWURGXFWLRQ RI WKH VHURORJLFDO FURVVPDWFK WHVW +RZHYHU KLJKO\

VHQVLWLVHGSDWLHQWVZLWKDSDQHOUHDFWLYHDQWLERG\ 35$ YDOXHRIRUPRUHUHPDLQRQ WKHZDLWLQJOLVWZLWKOLWWOHSURVSHFWRIDVXLWDEOH FURVVPDWFKQHJDWLYH GRQRU

7RLGHQWLI\SRWHQWLDOGRQRUVIRUKLJKO\VHQVLWLVHGSDWLHQWV'XTXHVQR\GHYHORSHGDFRPSXWHU SURJUDPFDOOHG+/$0DWFKPDNHU7KLVFRPSXWHUEDVHGDOJRULWKPIRFXVHVRQWKHVWUXFWXUDO

(5)

65 HLAMatchmaker and CTL SUHFXUVRU &7/S WHVWLVURXWLQHO\XVHGIRUWKHVHOHFWLRQRIGRQRUVIRUSDWLHQWVZKRQHHGD KDHPDWRSRLHWLFVWHPFHOOWUDQVSODQWDWLRQ7KH&7/SWHVWSURYLGHVLQVLJKWLQWRWKHIUHTXHQF\ RIGRQRU&7/VFDSDEOHRIUHVSRQGLQJWR+/$PLVPDWFKHVSUHVHQWRQWKHSDWLHQWVFHOOV,Q WKHSUHVHQWVWXG\LWZDVDQDO\VHGZKHWKHUWKHQXPEHURIWULSOHWPLVPDWFKHVEHWZHHQGRQRU DQGUHFLSLHQWLVDOVRSUHGLFWLYHIRUWKH&7/SIUHTXHQF\

Material and Methods

Patient and donor selection

7ZR JURXSV RI PLVPDWFKHG FRPELQDWLRQV ZHUH DQDO\VHG 7KH ¿UVW JURXS FRQFHUQHG  SDWLHQWGRQRUFRPELQDWLRQVUHJLVWHUHGDWWKH(XURSGRQRUIRXQGDWLRQ$OOLQGLYLGXDOVZHUH W\SHGIRU+/$FODVV,DQG+/$FODVV,,RQDKLJKUHVROXWLRQOHYHOE\'1$EDVHGW\SLQJ XVLQJ SRO\PHUDVH FKDLQ UHDFWLRQ VHTXHQFH VSHFL¿F SULPHUV 3&5663 DQG VHTXHQFLQJSRO\PHUDVH FKDLQ UHDFWLRQ VHTXHQFH VSHFL¿F SULPHUV 3&5663  DQG VHTXHQFLQJDQG VHTXHQFLQJ EDVHG W\SLQJ 6%7  $OO FRXSOHV KDG D VLQJOH +/$ FODVV , PLVPDWFK DW WKH DOOHOH OHYHO DQG ZHUH PDWFKHG IRU +/$'5% DQG '4%7KH JURXS FRQVLVWHG RI  VLQJOH +/$$ PLVPDWFKHGFRPELQDWLRQVVLQJOH+/$%PLVPDWFKHGFRPELQDWLRQVDQGVLQJOH+/$ &PLVPDWFKHGFRPELQDWLRQV$OOSDWLHQWGRQRUFRPELQDWLRQVZHUHDQDO\VHGIRUDOORUHDFWLYH &7/SIUHTXHQF\LQWKHJUDIWYHUVXVKRVWGLUHFWLRQ

7KHVHFRQGJURXSFRQFHUQHGKHDOWK\UHVSRQGHUVWLPXODWRUFRPELQDWLRQV$OOLQGLYLGXDOV ZHUH VHURORJLFDOO\ W\SHG IRU +/$$ % DQG ±'5 XVLQJ WKH VWDQGDUG 1,+ FRPSOHPHQW GHSHQGHQWF\WRWR[LFLW\DVVD\ &'& $OOFRPELQDWLRQVZHUHPLVPDWFKHGIRUDWOHDVWRQH+/$ FODVV,DQWLJHQ7KHJURXSFRQVLVWHGRI+/$'5LGHQWLFDODQG+/$'5PLVPDWFKHG FRPELQDWLRQV$OOFRPELQDWLRQVZHUHDQDO\VHGIRUDOORUHDFWLYH&7/SIUHTXHQFLHV

Cytotoxic T-Lymphocyte Precursor Test

7KHDQDO\VLVRI&7/SIUHTXHQFLHVE\OLPLWLQJGLOXWLRQDVVD\VLQWKHJUDIWYHUVXVKRVWGLUHFWLRQ ZHUHSHUIRUPHGDVGHVFULEHGE\=KDQJet al. %ULHÀ\WZRIROGGLOXWHGSHULSKHUDOEORRG

O\PSKRF\WHV 3%/ IURPWKHGRQRU IURPFHOOVSHUZHOOGRZQWR ZHUHFXOWXUHG LQUHSOLFDWHVZLWKLUUDGLDWHG *\ VWLPXODWRUFHOOV 3%/IURPWKHSDWLHQW LQ DWRWDOYROXPHRIPO$IWHUGD\VRIFXOWXUHLQ530, *LEFR3DLVOH\6FRWODQG  VXSSOHPHQWHGZLWKSHQLFLOOLQ 8POVWUHSWRP\FLQ+JPO JOXWDPLQ P0  KHDWLQDFWLYDWHGSRROHGKXPDQVHUXPDQG8PORIU,/ 2UWKR3KDUPDFHXWLFDO&RUS 5DULWDQ 1- 86$  WKH F\WRO\WLF DFWLYLW\ DJDLQWV&UODEHOHG WDUJHW FHOOV 3+$ FHOOV RI

WKH SDWLHQW  ZDV PHDVXUHG LQ HDFK ZHOO 7KH VXSHUQDWDQW ZDV KDUYHVWHG XVLQJ D 6NDWURQ KDUYHVWLQJV\VWHP /LHV1RUZD\ DQGWKHUHOHDVHRI&UZDVDVVD\HGLQD3DFNDUGJDPPD

FRXQWHU 3DOR$OWR&$86$ 

(6)

GLOXWHGUHVSRQGHU3%/ IURPFHOOVSHUZHOOGRZQWR ZHUHFXOWXUHGZLWK LUUDGLDWHG UDG VWLPXODWRUFHOOV$IWHUGD\VRIFXOWXUHLQ530,VXSSOHPHQWHG ZLWKKHDWLQDFWLYDWHGSRROHGKXPDQVHUXPDQG8PORIU,/ &HWXV$PVWHUGDP 7KH1HWKHUODQGV WKHF\WRO\WLFDFWLYLW\DJDLQVW(XURSLXPODEHOOHGWDUJHWFHOOVZDVPHDVXUHG LQHDFKZHOOXVLQJDWLPHUHVROYHGÀXRURPHWHU $UFXV:DOODF  ,QHDFKWHVWUHVSRQGHUFHOOVZHUHFXOWXUHGZLWKLUUDGLDWHGUHVSRQGHUFHOOVDVDQHJDWLYHFRQWURO 6WLPXODWRUDQGUHVSRQGHUFHOOVZHUHDOVRFXOWXUHGZLWK+/$PLVPDWFKHGWKLUGSDUW\FHOOV DVSRVLWLYHFRQWUROV,QWKHFKURPLXPUHOHDVHDVVD\DQHJDWLYH&7/SWHVWZDVGH¿QHGDV) 1 &7/SSHU3%/DKLJKUHVXOWDVRUPRUH&7/SSHU3%/,QWKH(XURSLXPUHOHDVH

DVVD\DQHJDWLYHUHVXOWZDVGH¿QHGDV)&7/SSHU3%/DQLQWHUPHGLDWHUHVXOWDV

&7/SSHU3%/DQGDKLJKUHVXOWDV!&7/SSHU3%/)UHTXHQFLHVRI&7/

SUHFXUVRUVZHUHFDOFXODWHGXVLQJWKH-DFNNQLIHPHWKRGDFFRUGLQJWR6WULMERVFKet al.12

Triplet mismatch analysis

7KHQXPEHURIWULSOHWPLVPDWFKHVZDVFDOFXODWHGIRUHYHU\UHVSRQGHUVWLPXODWRUFRPELQDWLRQ ZLWK XVH RI WKH +/$0DWFKPDNHU FRPSXWHU DOJRULWKP GHYHORSHG E\ 'XTXHVQR\ ,W ZDV

DQDO\VHGLIWKHQXPEHURIWULSOHWPLVPDWFKHVEHWZHHQUHVSRQGHUDQGVWLPXODWRULVSUHGLFWLYH IRU WKH &7/S IUHTXHQF\ DJDLQVW WKH VWLPXODWRU 7KH 0DQQ:KLWQH\ U WHVW ZDV XVHG IRU VWDWLVWLFDOFRPSDULVRQ

Results

(7)

67 HLAMatchmaker and CTL )SHU3%/ 3  %HWZHHQFRPELQDWLRQVZLWKD&7/SIUHTXHQF\)DQGD&7/S IUHTXHQF\EHWZHHQDQGSHU3%/QRVLJQL¿FDQWGLIIHUHQFHLQWKHQXPEHURIWULSOHW PLVPDWFKHVZDVIRXQG ¿JXUH :KHQWKH+/$'5PDWFKHGDQG+/$'5PLVPDWFKHG FRPELQDWLRQVZHUHDQDO\VHGVHSDUDWHO\VLPLODUUHVXOWVZHUHREWDLQHG GDWDQRWVKRZQ  $QRWKHUDQDO\VLVZDVSHUIRUPHGXVLQJWKHSDWLHQWGRQRUFRPELQDWLRQVIURPWKH(XURSGRQRU SRSXODWLRQZLWKDVLQJOH+/$$%RU&PLVPDWFK7KH&7/SIUHTXHQF\ZDVDQDO\VHGIRU DOOSDWLHQWDQGGRQRUFRPELQDWLRQVZLWK]HURRU*WULSOHWPLVPDWFKHV7KH&7/SIUHTXHQF\ DJDLQVWWKH]HURWULSOHWPLVPDWFKHGSDWLHQWVZDVQRWVLJQL¿FDQWO\ORZHUFRPSDUHGZLWKWKH FRPELQDWLRQVZLWKRUPRUHWULSOHWPLVPDWFKHV 3   ¿JXUH 

Figure 1. Number of triplet mismatches in patient/donor combinations from the donor registry of the Europdonor foundation with a single HLA-A or -B mismatch and a CTLp frequency • 1 (left panel) or a CTLp frequency – 10 (right panel) per 106 PBL. Horizontal bars represent

(8)

Figure 2. Number of triplet mismatches in healthy responder/ stimulator combinations mismatched for at least one HLA class I antigen and a CTLp frequency • 10 (left), a CTLp frequency between 11 and 100 (middle) or a CTLp frequency > 100 (right) per 106 PBL. Horizontal bars represent the mean of the group.

According to Mann-Whitney U test only the combinations with a &7/S IUHTXHQF\ ! VKRZHG D VLJQL¿FDQWO\ KLJKHU QXPEHU RI triplet mismatches compared with the combinations with a CTLp frequency between 11 and 100 (P=0.03) and a CTLp frequency • 10 (P=0.04) per 106 PBL.

(9)

69 HLAMatchmaker and CTL

Discussion

2QEDVLVRIWKH+/$0DWFKPDNHUDOJRULWKPFHUWDLQ+/$FODVV,PLVPDWFKHGFRPELQDWLRQV PD\EHIXOO\FRPSDWLEOHDWWKHWULSOHWOHYHO7KHFOLQLFDOUHOHYDQFHRIWKH+/$0DWFKPDNHU SURJUDPZDVVKRZQE\LWVDELOLW\WRLGHQWLI\DFFHSWDEOHPLVPDWFKHVIRU KLJKO\ VHQVLWLVHG SDWLHQWVDQGWRSUHGLFWWKHRXWFRPHRIFURVVPDWFKUHVXOWV)XUWKHUPRUHLQFDVHRI+/$ '5FRPSDWLELOLW\EHWZHHQSDWLHQWDQGNLGQH\GRQRU+/$$%PLVPDWFKHGJUDIWVWKDWZHUH PDWFKHGDWWKHWULSOHWOHYHOVKRZHGDVLPLODUJUDIWVXUYLYDODV]HUR+/$$%PLVPDWFKHG grafts

+/$0DWFKPDNHU FDQ DOVR EH XVHG WR RSWLPLVH GRQRUUHFLSLHQW FRPSDWLELOLW\ WKHUHE\ SUHYHQWLQJRUUHGXFLQJDQWLERG\PHGLDWHGUHMHFWLRQRIRUJDQWUDQVSODQWV7+RZHYHUQH[W

WRDQWLERGLHVF\WRWR[LF7O\PSKRF\WHV &7/ SOD\DPDMRUUROHLQWUDQVSODQWUHMHFWLRQ$VD WRROWRPRQLWRUDOORUHDFWLYLW\in vitro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

(10)

7KH SUHVHQW VWXG\ LQGLFDWHV WKDW LW LV QRW SRVVLEOH WR VHOHFW ERQH PDUURZ GRQRUV WKDW ZLOO QRW IRUP D &7/S UHVSRQVH E\ DQDO\VLQJ WKH QXPEHU RI WULSOHW PLVPDWFKHVXVLQJ WKH +/$0DWFKPDNHUDOJRULWKP$ORZQXPEHURIWULSOHWPLVPDWFKHVFDQOHDGWRHLWKHUDORZRU DKLJK&7/SIUHTXHQF\,QDIXWXUHVWXG\LWZLOOEHDQDO\VHGLIVSHFL¿FDPLQRDFLGVHTXHQFH GLIIHUHQFHVEHWZHHQGRQRUDQGUHFLSLHQWORFDWHGLQWKHJURRYHRIWKH+/$PROHFXOHDUH DVVRFLDWHGZLWKDKLJKRUORZ&7/UHVSRQVHDVLVVXJJHVWHGE\DUHFHQWVWXG\RI)HUUDUDet

al.22DQG2XGVKRRUQet al.237KHVHVWXGLHVVKRZHGWKDWDPLQRDFLGVDWGLIIHUHQWSRVLWLRQVRI

(11)

71

HLAMatchmaker and CTL

References

   0F.HQQD507DNHPRWR6.7HUDVDNL3,$QWL+/$DQWLERGLHVDIWHUVROLGRUJDQWUDQV-SODQWDWLRQ7UDQVSODQWDWLRQ

   6XPLWUDQ+ROJHUVVRQ 6 +/$VSHFL¿F DOORDQWLERGLHV DQG UHQDO JUDIW RXWFRPH 1HSKURO 'LDO7UDQVSODQW

   6FRUQLN-&%UXQVRQ0(+RZDUG5-3IDII::$OORLPPXQL]DWLRQPHPRU\DQGWKHLQ-WHUSUHWDWLRQRIFURVVPDWFKUHVXOWVIRUUHQDOWUDQVSODQWDWLRQ7UDQVSODQWDWLRQ 

   5HJDQ/%UDXGH35+LOO'3$SURVSHFWLYHVWXG\RIWKHLQFLGHQFHWLPHRIDSSHDUDQFH DQG VLJQL¿FDQFH RI DQWLSDWHUQDO O\PSKRF\WRWR[LF DQWLERGLHV LQ KXPDQ SUHJQDQF\ +XP 5HSURG

   3DWHO57HUDVDNL3,6LJQL¿FDQFHRIWKHSRVLWLYHFURVVPDWFKWHVWLQNLGQH\WUDQVSODQWDWLRQ 1(QJO-0HG

   'XTXHVQR\ 5- +/$0DWFKPDNHU D PROHFXODUO\ EDVHG DOJRULWKP IRU KLVWRFRPSDWLELOLW\ GHWHUPLQDWLRQ,'HVFULSWLRQRIWKHDOJRULWKP+XP ,PPXQRO +XP,PPXQRO

   'DQNHUV0.$:LWYOLHW0'5RHOHQ'/HWDO7KH QXPEHU RI DPLQR DFLG VHTXHQFH GLI 7KHQXPEHURIDPLQRDFLGVHTXHQFHGLI-IHUHQFHV EHWZHHQ SDWLHQW DQG GRQRU LV SUHGLFWLYH IRU WKH DQWLERG\ UHDFWLYLW\ DJDLQVW WKH PLVPDWFKHG+/$DQWLJHQV7UDQVSODQWDWLRQ

   .DPLQVNL ( 6KDUURFN & +RZV - HW DO )UHTXHQF\ DQDO\VLV RI F\WRWR[LF 7 O\PSKRF\WHHW DO )UHTXHQF\ DQDO\VLV RI F\WRWR[LF 7 O\PSKRF\WH)UHTXHQF\ DQDO\VLV RI F\WRWR[LF 7 O\PSKRF\WH SUHFXUVRUV±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

(12)

  9RUKDEHQ 5 3HUYLV . /DYLQJLD % 6WDVWQ\ 3 3UHGLFWLYH YDOXHV IRU D QHJDWLYH FURVVPDWFK9RUKDEHQ53HUYLV./DYLQJLD%6WDVWQ\33UHGLFWLYHYDOXHVIRUDQHJDWLYHFURVVPDWFK RIVHQVLWL]HGUHQDOUHFLSLHQWVWULSOHWDPLQRDFLGPDWFKLQJYV&5(*PDWFKLQJ+XP ,P +XP,P-PXQRO

  /REDVKHYVN\$/6HQNEHLO5:6KRDI-/HWDO7KH QXPEHU RI DPLQR DFLG UHVLGXHV PLV 7KHQXPEHURIDPLQRDFLGUHVLGXHVPLV-PDWFKHVFRUUHODWHVZLWKÀRZF\WRPHWU\FURVVPDWFKLQJUHVXOWVLQKLJK35$UHQDOSDWLHQWV +XP,PPXQRO

  'XTXHVQR\ 5- 7DNHPRWR 6 GH /DQJH 3 HW DO +/$0DWFKPDNHU D PROHFXODUO\ EDVHG+/$0DWFKPDNHU D PROHFXODUO\ EDVHG DOJRULWKP IRU KLVWRFRPSDWLELOLW\ GHWHUPLQDWLRQ ,,, (IIHFW RI PDWFKLQJ DW WKH +/$$% DPLQRDFLGWULSOHWOHYHORQNLGQH\WUDQVSODQWVXUYLYDO7UDQVSODQWDWLRQ 7UDQVSODQWDWLRQ   +HU]RJ:5=DQNHU%,UVFKLFN(8HWDO6HOHFWLYH UHGXFWLRQ RI GRQRUVSHFL¿F F\WRWR[LF6HOHFWLYHUHGXFWLRQRIGRQRUVSHFL¿FF\WRWR[LF

7O\PSKRF\WHSUHFXUVRUVLQSDWLHQWVZLWKDZHOOIXQFWLRQLQJNLGQH\DOORJUDIW7UDQVSODQWD-WLRQ

  5HDGHU-$ %XUNH 00 &RXQLKDQ 3 HW DO 1RQLQYDVLYH PRQLWRULQJ RI KXPDQ FDUGLDF DO 5HDGHU-$%XUNH00&RXQLKDQ3HWDO1RQLQYDVLYHPRQLWRULQJRIKXPDQFDUGLDFDO-ORJUDIWUHMHFWLRQ7UDQVSODQWDWLRQ

  6WHLQPDQQ - /HLPHQVWROO * (QJHPDQQ 5 :H\DQG 0 :HVWSKDO 0 0XOOHU5XFKKROW] :6WHLQPDQQ-/HLPHQVWROO*(QJHPDQQ5:H\DQG0:HVWSKDO00XOOHU5XFKKROW]: &OLQLFDOUHOHYDQFHRIF\WRWR[LF7FHOOSUHFXUVRU S&7/ IUHTXHQFLHVLQDOORJUDIWUHFLSLHQWV 7UDQVSO3URF

  ,UVFKLFN (8 +ODGLN ) %HUJHU 0 HW DO &ORQDO UHGXFWLRQ RI &7/S DQG DFTXLUHG DOORJUDIW,UVFKLFN(8+ODGLN)%HUJHU0HWDO&ORQDO UHGXFWLRQ RI &7/S DQG DFTXLUHG DOORJUDIW&ORQDOUHGXFWLRQRI&7/SDQGDFTXLUHGDOORJUDIW WROHUDQFHLQYDULRXVKXPDQWUDQVSODQWDWLRQPRGHOV7UDQVSO3URF   .DPLQVNL ( +RZV - 0DQ 6 %URRNHV 3 HW DO 3UHGLFWLRQ RI JUDIW YHUVXV KRVW GLVHDVH E\.DPLQVNL(+RZV-0DQ6%URRNHV3HWDO3UHGLFWLRQRIJUDIWYHUVXVKRVWGLVHDVHE\

IUHTXHQF\DQDO\VLVRIF\WRWR[LF7FHOOVDIWHUXQUHODWHGGRQRUERQHPDUURZWUDQVSODQWDWLRQ 7UDQVSODQWDWLRQ

  *RXOP\ ( +XPDQ PLQRU KLVWRFRPSDWLELOW\ DQWLJHQV &XUU 2SLQ ,PPXQRO *RXOP\ ( +XPDQ PLQRU KLVWRFRPSDWLELOW\ DQWLJHQV &XUU 2SLQ ,PPXQRO  

  )HUUDUD *% %DFLJDOXSR $ /DPSDUHOOL 7 HW DO %RQH PDUURZ WUDQVSODQWDWLRQ IURP XQUH )HUUDUD*%%DFLJDOXSR$/DPSDUHOOL7HWDO%RQHPDUURZWUDQVSODQWDWLRQIURPXQUH-ODWHGGRQRUVWKHLPSDFWRIPLVPDWFKHVZLWKVXEVWLWXWLRQVDWSRVLWLRQRIWKHKXPDQ OHXNRF\WHDQWLJHQFODVV,KHDY\FKDLQ%ORRG %ORRG

(13)

Referenties

GERELATEERDE DOCUMENTEN

)LJXUH   LV WKH FHQWUDO HQ]\PH LQ WKH FRDJXODWLRQ FDVFDGH DV LW LV WKH RXWFRPH RI

The relation between the SSM score of donor/patient couples with a single HLA-A or -B allele mismatch and T cell alloreactivity in vitro (CTLp/10 6 PBL).. The number of pairs in

Figure 1: Number of amino acid differences of single HLA class I incompatibilities versus T cell alloreactivity in vitro (CTLp/106 PBL). Horizontal lines indicate the mean of

Transplanting a single MHC class I mismatched graft from a female donor to a male recipient had significant adverse effect on transplantation outcome independent

127 VHDUFKWLPHVSDQ WREHVXEPLWWHG 7KHPHGLDQWLPHQHHGHGWR¿QGDGRQRUIRUSDWLHQWV RI 1RUWKZHVW (XURSHDQ RULJLQ GHFUHDVHG IURP  PRQWKV WR  PRQWKV DQG

JURRW DDQWDO EORHGNDQNHUV ]RDOV OHXNHPLH HQ EORHGVWRRUQLVVHQ ]RDOV HUQVWLJH YRUPHQ YDQ DDQJHERUHQ EORHGDUPRHGH RI HHQ VOHFKW IXQFWLRQHUHQG DIZHHUV\VWHHP

0DUWLQ%DUWKRORPHXV$OH[DQGHU+HHPVNHUNZHUGJHERUHQRSMXQLWH+DDUOHP$DQ KHW 0HQGHO &ROOHJH WH +DDUOHP EHKDDOGH KLM LQ  ]LMQ +$92 GLSORPD HQ LQ

Allogeneic haematopoietic stem cell donation and transplantation across the MHC class I barrier: "Faster is better than more.. More is better